Product Name :
LY3295668
Description:
LY3295668 (AK-01) is a potent, orally active and specific inhibitor of Aurora A kinase with Ki of 0.8 nM and 1038 nM for AURKA and AURKB, respectively.
CAS:
1919888-06-4
Molecular Weight:
489.95
Formula:
C24H26ClF2N5O2
Chemical Name:
(2R,4R)-1-(3-chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid
Smiles :
CC1=CC(NC2=CC=C(F)C(C[C@@]3(C[C@@H](C)N(CC3)CC3=CC=CC(Cl)=C3F)C(O)=O)=N2)=NN1
InChiKey:
YQQZZYYQTCPEAS-OYLFLEFRSA-N
InChi :
InChI=1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
LY3295668 (AK-01) is a potent, orally active and specific inhibitor of Aurora A kinase with Ki of 0.8 nM and 1038 nM for AURKA and AURKB, respectively.|Product information|CAS Number: 1919888-06-4|Molecular Weight: 489.95|Formula: C24H26ClF2N5O2|Chemical Name: (2R,4R)-1-(3-chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid|Smiles: CC1=CC(NC2=CC=C(F)C(C[C@@]3(C[C@@H](C)N(CC3)CC3=CC=CC(Cl)=C3F)C(O)=O)=N2)=NN1|InChiKey: YQQZZYYQTCPEAS-OYLFLEFRSA-N|InChi: InChI=1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO: 98 mg/mL(200.{{Fenoprofen} web|{Fenoprofen} GPCR/G Protein|{Fenoprofen} Biological Activity|{Fenoprofen} Data Sheet|{Fenoprofen} supplier|{Fenoprofen} Epigenetic Reader Domain} 02 mM).{{Anti-HA Affinity Gel} web|{Anti-HA Affinity Gel} Immunology/Inflammation|{Anti-HA Affinity Gel} Technical Information|{Anti-HA Affinity Gel} Formula|{Anti-HA Affinity Gel} custom synthesis} |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:27017949 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|LY3295668, an AURKA inhibitor with over 1, 000-fold selectivity versus AURKB, is distinguished by minimal toxicity to bone marrow cells at concentrations active against RB1mut cancer cells.|In Vivo:|LY3295668 leads to durable regression of RB1mut tumor xenografts at exposures that are well tolerated in rodents. Genetic suppression screens identifi ed enforcers of the spindle-assembly checkpoint (SAC) as essential for LY3295668 cytotoxicity in RB1-defi cient cancers and suggest a model in which a primed SAC creates a unique dependency on AURKA for mitotic exit and survival.|References:|Xueqian Gong, et al. Cancer Discov. 2019 Feb;9(2):248-263.Products are for research use only. Not for human use.|
